Alnylam Pharmaceuticals
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell ALNY and other ETFs, options, and stocks.About ALNY
Alnylam Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the business of developing and commercializing novel therapeutics based on ribonucleic acid interference. The company was founded by Noble Laureate, David Bartel, Thomas Tuschl, Phillip Zamore, Paul R.
ALNY Key Statistics
Stock Snapshot
Alnylam Pharmaceuticals(ALNY) stock is priced at $297.45, giving the company a market capitalization of 39.72B. It carries a P/E multiple of 71.40.
During the trading session on 2026-05-22, Alnylam Pharmaceuticals(ALNY) shares reached a daily high of $303.33 and a low of $294.99. At a current price of $297.45, the stock is +0.8% higher than the low and still -1.9% under the high.
Trading activity shows a volume of 630.31K, compared to an average daily volume of 914.92K.
The stock's 52-week range extends from a low of $284.19 to a high of $495.55.
The stock's 52-week range extends from a low of $284.19 to a high of $495.55.
ALNY News
...
Citi initiated coverage of Alnylam (ALNY) with a Buy rating and $380 price target The expanded launch of Amvuttra for ATTR-CM has “no doubt been impressive,” sa...
Analyst ratings
71%
of 31 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.